EP1011695 - Bibliographic data
USE OF NEUROTOXIN THERAPY FOR TREATMENT OF PROSTATE DISORDERS
| Last update | 16/07/2025 |
|---|---|
| Legal status | Invention expirée |
| Origin | Euro-PCT |
| (73) Holder |
ALLERGAN INC. 2525 Dupont Drive
Irvine CA 92612
États-Unis d'Amérique
|
|---|---|
| (72) Inventors |
SCHMIDT, Richard, A. 12136 W. 75th Lane
Arvada, CO 80005
États-Unis d'Amérique
KAULA, Norbert, F. 4200 East Ninth Ave., C 319
Denver, CO 80262
États-Unis d'Amérique
|
| (74) Agent |
Mail recipient CABINET MANASSE immeuble Est-Ouest -
24 bd Princesse Charlotte
98000
MONACO
Principauté de Monaco
|
| (21) Request number | EP98933345.5 |
|---|---|
| (22) Request date | 15/07/1998 |
| (11) Publication number | EP1011695 |
|---|---|
| Publication date | 22/03/2006 |
| (54) Title of the invention | USE OF NEUROTOXIN THERAPY FOR TREATMENT OF PROSTATE DISORDERS |
|---|---|
| (51) International classification | A61K 35/00, A61K 38/48, A61K 38/17, A61K 31/505, A61K 31/335, A61K 31/165, A61P 13/08 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 52580 P |
|---|---|
| Initial application | None |
| Divisional application | EP04019371.6 /EP1475099EP04026167.9 /EP1502601EP05024445.8 /EP1658858 None |
| Expected annuity | None |
|---|---|
| Last annuity | Annuity: 20 - Payment date 22/06/2017 |
| Publication | BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2006/1, of 31/03/2006 CHANGEMENT D'ADRESSE - bulletin 2017/18, of 05/05/2017 CHANGEMENT D'ADRESSE - bulletin 2017/18, of 05/05/2017 CESSION - bulletin 2017/18, of 05/05/2017 |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 22/03/2006 Modification du mandataire OEB du brevet européen - Legal date 25/04/2007 Modification du titre en français de l’invention du brevet européen - Legal date 18/02/2009 Constitution de mandataire pour un dossier - Legal date 22/03/2017 Expiration de l'invention - Legal date 16/07/2018 |